IMUX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Immunic Inc (IMUX).


$90.08M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

IMUX Market Cap. (MRY)


IMUX Shares Outstanding (MRY)


IMUX Assets (MRY)


Total Assets

$40.87M

Total Liabilities

$22.44M

Total Investments

$0

IMUX Income (MRY)


Revenue

$0

Net Income

-$100.51M

Operating Expense

$98.05M

IMUX Cash Flow (MRY)


CF Operations

-$84.77M

CF Investing

-$264.00K

CF Financing

$74.54M

IMUX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IMUX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$40,868,000 (-24.74%)

$54,299,000 (-57.50%)

$127,753,000 (-8.16%)

$139,100,000 (-17.13%)

Assets Current

$39,332,000 (-25.13%)

$52,534,000 (-58.26%)

$125,864,000 (19.88%)

$104,988,000 (-21.50%)

Assets Non-Current

$1,536,000 (-12.97%)

$1,765,000 (-6.56%)

$1,889,000 (-94.46%)

$34,112,000 (-0.01%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$32,970,000 (0.00%)

Shareholders Equity

$18,429,000 (-36.30%)

$28,931,000 (-74.55%)

$113,684,000 (-10.57%)

$127,115,000 (-19.95%)

Property Plant & Equipment Net

$1,536,000 (-12.97%)

$1,765,000 (-4.39%)

$1,846,000 (67.82%)

$1,100,000 (-0.36%)

Cash & Equivalents

$35,668,000 (-23.58%)

$46,674,000 (-56.28%)

$106,745,000 (22.89%)

$86,863,000 (-31.85%)

Accumulated Other Comprehensive Income

$4,209,000 (11.97%)

$3,759,000 (23.86%)

$3,035,000 (1304.37%)

-$252,000 (93.87%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$9,629,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$9,629,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$7,846,000 (53.87%)

$5,099,000 (19.11%)

$4,281,000 (14.31%)

$3,745,000 (1.22%)

Accumulated Retained Earnings (Deficit)

-$511,399,000 (-24.46%)

-$410,892,000 (-29.50%)

-$317,280,000 (-61.16%)

-$196,873,000 (-89.43%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$264,000 (-58.69%)

$639,000 (-35.58%)

$992,000 (69.86%)

$584,000 (-13.99%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$264,000 (-58.69%)

$639,000 (-35.58%)

$992,000 (69.86%)

$584,000 (-13.99%)

Total Liabilities

$22,439,000 (-11.55%)

$25,368,000 (80.31%)

$14,069,000 (17.39%)

$11,985,000 (32.05%)

Liabilities Current

$22,175,000 (-10.33%)

$24,729,000 (89.10%)

$13,077,000 (14.70%)

$11,401,000 (35.77%)

Liabilities Non-Current

$264,000 (-58.69%)

$639,000 (-35.58%)

$992,000 (69.86%)

$584,000 (-13.99%)

IMUX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$18,006,000 (12.48%)

$16,008,000 (4.88%)

$15,263,000 (-50.04%)

$30,550,000 (195.63%)

Research & Development Expense

$80,046,000 (-3.81%)

$83,215,000 (16.78%)

$71,255,000 (16.59%)

$61,115,000 (58.18%)

Operating Expenses

$98,052,000 (-1.18%)

$99,223,000 (-16.96%)

$119,488,000 (30.35%)

$91,665,000 (87.18%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$100,507,000 (-7.37%)

-$93,612,000 (22.25%)

-$120,407,000 (-29.55%)

-$92,945,000 (-111.16%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$100,507,000 (-7.37%)

-$93,612,000 (22.25%)

-$120,407,000 (-29.55%)

-$92,945,000 (-111.16%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$100,507,000 (-7.37%)

-$93,612,000 (22.25%)

-$120,407,000 (-29.55%)

-$92,945,000 (-111.16%)

Weighted Average Shares

$100,174,766 (126.03%)

$44,320,050 (39.29%)

$31,819,006 (34.53%)

$23,652,779 (51.00%)

Weighted Average Shares Diluted

$100,174,766 (126.03%)

$44,320,050 (39.29%)

$31,819,006 (34.53%)

$23,652,779 (51.00%)

Earning Before Interest & Taxes (EBIT)

-$100,507,000 (-7.37%)

-$93,612,000 (22.25%)

-$120,407,000 (-29.55%)

-$92,945,000 (-111.16%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$98,052,000 (1.18%)

-$99,223,000 (16.96%)

-$119,488,000 (-30.35%)

-$91,665,000 (-87.18%)

IMUX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$264,000 (-102.79%)

$9,462,000 (197.14%)

-$9,741,000 (-14438.81%)

-$67,000 (54.11%)

Net Cash Flow from Financing

$74,541,000 (7115.97%)

$1,033,000 (-98.92%)

$95,760,000 (123.52%)

$42,841,000 (-70.34%)

Net Cash Flow from Operations

-$84,766,000 (-19.68%)

-$70,828,000 (-8.73%)

-$65,144,000 (21.73%)

-$83,233,000 (-80.45%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,006,000 (81.68%)

-$60,071,000 (-402.14%)

$19,882,000 (148.98%)

-$40,589,000 (-141.38%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$9,796,000 (201.73%)

-$9,629,000 (0%)

$0 (0%)

Capital Expenditure

-$264,000 (20.96%)

-$334,000 (-198.21%)

-$112,000 (-67.16%)

-$67,000 (54.11%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$74,541,000 (7490.73%)

$982,000 (-98.97%)

$95,760,000 (123.52%)

$42,841,000 (-70.34%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$517,000 (-297.33%)

$262,000 (126.38%)

-$993,000 (-663.85%)

-$130,000 (-66.67%)

Share Based Compensation

$8,527,000 (20.06%)

$7,102,000 (-10.43%)

$7,929,000 (33.28%)

$5,949,000 (116.56%)

Depreciation Amortization & Accretion

$134,000 (20.72%)

$111,000 (44.16%)

$77,000 (-9.41%)

$85,000 (117.95%)

IMUX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-194.40% (-23.51%)

-157.40% (-59.63%)

-98.60% (-40.86%)

-70.00% (-79.03%)

Return on Average Assets (ROAA)

-135.70% (-15.59%)

-117.40% (-31.03%)

-89.60% (-41.32%)

-63.40% (-74.18%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

641.20% (-47.62%)

1224.10% (179.83%)

-1533.40% (76.74%)

-6593.00% (-231.47%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1 (-40.65%)

-0.71 (-92.16%)

-0.37 (84.80%)

-2.44 (55.25%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

4.89 (108.80%)

2.34 (384.68%)

0.48 (-75.56%)

1.98 (-0.95%)

Debt to Equity Ratio (D/E)

1.22 (38.88%)

0.88 (607.26%)

0.12 (31.91%)

0.09 (64.91%)

Earnings Per Share (EPS)

-1 (52.61%)

-2.11 (44.18%)

-3.78 (3.82%)

-3.93 (-39.86%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.85 (47.14%)

-1.61 (21.70%)

-2.05 (41.77%)

-3.52 (-19.23%)

Book Value Per Share (BVPS)

0.18 (-71.82%)

0.65 (-81.72%)

3.57 (-33.51%)

5.37 (-46.99%)

Tangible Assets Book Value Per Share (TABVPS)

0.41 (-66.69%)

1.23 (-69.49%)

4.01 (-10.52%)

4.49 (-47.90%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-2 (50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.31 (-230.85%)

-0.09 (-166.20%)

0.14 (109.32%)

-1.52 (63.67%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

1.77 (-16.48%)

2.12 (-77.93%)

9.63 (4.52%)

9.21 (-42.18%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$85,030,000 (-19.49%)

-$71,162,000 (-9.05%)

-$65,256,000 (21.66%)

-$83,300,000 (-80.03%)

Enterprise Value (EV)

$31,194,016 (253.75%)

$8,818,074 (151.73%)

-$17,045,834 (-112.05%)

$141,464,131 (-23.26%)

Earnings Before Tax (EBT)

-$100,507,000 (-7.37%)

-$93,612,000 (22.25%)

-$120,407,000 (-29.55%)

-$92,945,000 (-111.16%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$100,373,000 (-7.35%)

-$93,501,000 (22.30%)

-$120,330,000 (-29.58%)

-$92,860,000 (-111.15%)

Invested Capital

-$16,711,000 (-1.49%)

-$16,465,000 (-284.52%)

$8,923,000 (5.60%)

$8,450,000 (3128.67%)

Working Capital

$17,157,000 (-38.30%)

$27,805,000 (-75.35%)

$112,787,000 (20.52%)

$93,587,000 (-25.34%)

Tangible Asset Value

$40,868,000 (-24.74%)

$54,299,000 (-57.50%)

$127,753,000 (20.37%)

$106,130,000 (-21.32%)

Market Capitalization

$90,079,016 (33.02%)

$67,718,074 (23.20%)

$54,966,166 (-78.12%)

$251,207,131 (-20.70%)

Average Equity

$51,699,250 (-13.05%)

$59,460,000 (-51.29%)

$122,075,750 (-8.00%)

$132,692,000 (17.73%)

Average Assets

$74,069,000 (-7.09%)

$79,721,750 (-40.66%)

$134,353,250 (-8.39%)

$146,659,750 (21.22%)

Invested Capital Average

-$15,676,000 (-104.98%)

-$7,647,500 (-197.39%)

$7,852,250 (457.00%)

$1,409,750 (260.61%)

Shares

90,079,016 (99.53%)

45,145,383 (14.99%)

39,261,547 (49.57%)

26,249,439 (26.70%)